Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-07

Clinical Trial Update: Safety and Efficacy of Propranolol Eye Drops in Treating Retinopathy of Premature [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting safety and efficacy of propranolol eye drops for treating retinopathy of prematurity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propranolol eye drops (propranolol)

Snippet

Sponsor: Meyer Children's Hospital IRCCS | Conditions: Retinopathy of Prematurity | Phase 2 | Status: COMPLETED